Tranexamic OrPha 500 mg/5 ml, Injektionslösung

7680690070014 CH-69007 Injektionslösung
Tranexamic OrPha 500 mg/5 ml, Injektionslösung
Tranexamic OrPha 500 mg/5 ml, Injektionslösung
Tranexamic OrPha 500 mg/5 ml, Injektionslösung
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
12/06/2024
Summary of Product Characteristics
Français
12/06/2024
Summary of Product Characteristics
Italien
12/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
69007
Drug name
Tranexamic OrPha, Injektionslösung
Galenic form
LSINJ
ATC Code
B02AA02
Authorization status
Z
Dispensing category
B
First authorization
10/03/2023
Authorization expiration date
09/03/2028
IT Number
06.06.0.
Domain
Human medicine
Field of application
Antifibrinolytikum, Haemostatikum

Package details

Description (FR)
TRANEXAMIC OrPha sol inj 500 mg/5ml 10 amp 5 ml
Description (DE)
TRANEXAMIC OrPha Inj Lös 500 mg/5ml 10 Amp 5 ml
Market launch
10/03/2023
Narcotic (BTM)
No

Other package sizes (1)

TRANEXAMIC OrPha sol inj 1000 mg/10ml 10 amp 10 ml
10 AMP
GTIN: 7680690070021
View